Beijing Cancer hospital-Thoracic Cancer Department A ( Site 2901)

Beijing, Beijing Municipality 100142

0 studies enrolling now · 1 studies all time

What they study most

Small Cell Lung Carcinoma

Studies at this site

• Pembrolizumab/Vibostolimab (MK-7684A) or Atezolizumab in Combination With Chemotherapy in First Line Treatment of Extensive-Stage Small Cell Lung Cancer (MK-7684A-008/KEYVIBE-008) — Running, not enrolling